Torsten Haack

Conformational Control Inhibition of the BCR-ABL1 Tyrosine Kinase, Including the Gatekeeper T315I Mutant, by the Switch-Control Inhibitor DCC-2036

Wayne W. Chan, Scott Wise, Michael D. Kaufman et al. · Cancer Cell · 2011 · 204 citations · Full text

Switch-control Inhibitor Dcc-2036, Signal Transduction, Signaling Pathway +9

A novel dual glucagon‐like peptide and glucagon receptor agonist SAR425899: Results of randomized, placebo‐controlled first‐in‐human and first‐in‐patient trials

J. Tillner, Maximilian Posch, Frank Wagner et al. · Diabetes Obesity and Metabolism · 2018 · 160 citations

Design of Novel Exendin-Based Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists

Andreas Evers, Torsten Haack, M. Lorenz et al. · Journal of Medicinal Chemistry · 2017 · 98 citations · Full text

Biochemistry, Functional Selectivity, Medicine +14

Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists Specifically Optimized for Multidose Formulations

Andreas Evers, Martin Bossart, Stefania Pfeiffer‐Marek et al. · Journal of Medicinal Chemistry · 2018 · 49 citations · Full text

Peptide Engineering, Glycobiology, Pharmacotherapy +16

Receptor occupancy of dual glucagon-like peptide 1/glucagon receptor agonist SAR425899 in individuals with type 2 diabetes

Olof Eriksson, Torsten Haack, Youssef Hijazi et al. · Scientific Reports · 2020 · 43 citations · Full text